Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-06

Clinical Trial Update: Safety and Efficacy of Tripalmitoleoylglycerol in the Treatment of Dermatitis [NA]

View source ↗

Summary

A completed clinical trial evaluated the safety and efficacy of tripalmitoleoylglycerol for dermatitis, using skin barrier measures and dermatitis severity indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tripalmitoleoylglycerol (tripalmitoleoylglycerol)

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Skin Barrier to Water Loss, PASI /SCORAD Index | NA | Status: COMPLETED